Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A

被引:34
作者
Kamstrup, S [1 ]
San Martin, R
Doberti, A
Grande, H
Dalsgaard, K
机构
[1] Danish Vet Inst Virus Res, DK-4771 Kalvehave, Denmark
[2] Catholic Univ Chile, Dept Chem Engn, Santiago, Chile
[3] Licentech, NL-3503 RH Utrecht, Netherlands
关键词
Quil A; adjuvant; saponin; ISCOM;
D O I
10.1016/S0264-410X(99)00560-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunisation against pathogens remains one of the most effective ways of preventing or reducing losses due to infectious diseases in animal husbandry. When inactivated vaccines are used, adjuvants are most often required to obtain satisfactory immune responses. One such type of adjuvant is saponin derived from the bark of Quillaja saponaria Molina, a tree of the rose family. A few different commercial sources exist, but due to the structural complexity and heterogeneity of these saponin preparations, it has been difficult to establish exactly which components are responsible for the adjuvant activity. By carefully selecting the bark source, live have succeeded in preparing a much less heterogeneous preparation of quillaja saponin. In this report we describe the preparation, in terms of structural complexity, hemolytic activity, adjuvant activity, and its ability to form ISCOM matrix. This new preparation could have implications for use per se, or as starting material for more effective preparation of pure substances. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2244 / 2249
页数:6
相关论文
共 16 条
[1]   SIMPLE METHOD FOR LARGE-SCALE PREPARATION OF SUCROSE GRADIENTS [J].
BAXTERGABBARD, KL .
FEBS LETTERS, 1972, 20 (01) :117-+
[2]   METHOD FOR MONITORING ULTRACENTRIFUGE GRADIENTS USING A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DIODE-ARRAY DETECTOR [J].
BEEKMAN, N ;
KAMSTRUP, S ;
DALSGAARD, K .
ANALYTICAL BIOCHEMISTRY, 1995, 228 (01) :168-169
[3]   Development of a single-shot subunit vaccine for HIV-1 .3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120 [J].
Cleland, JL ;
Barron, L ;
Daugherty, A ;
Eastman, D ;
Kensil, C ;
Lim, A ;
Weissburg, RP ;
Wrin, T ;
Vennari, J ;
Powell, MF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1350-1357
[4]   ADJUVANT ACTIVITY OF QS-21 FOR EXPERIMENTAL ESCHERICHIA-COLI-018 POLYSACCHARIDE VACCINES [J].
COUGHLIN, RT ;
FATTOM, A ;
CHU, CY ;
WHITE, AC ;
WINSTON, S .
VACCINE, 1995, 13 (01) :17-21
[5]   SAPONIN ADJUVANTS .3. ISOLATION OF A SUBSTANCE FROM QUILLAJA SAPONARIA MOLINA WITH ADJUVANT ACTIVITY IN FOOT-AND-MOUTH-DISEASE VACCINES [J].
DALSGAARD, K .
ARCHIV FUR DIE GESAMTE VIRUSFORSCHUNG, 1974, 44 (03) :243-254
[6]  
ESPINET EG, 1951, GAC VET, V74, P1
[7]   FORMULATION OF THE PURIFIED FUSION PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS WITH THE SAPONIN QS-21 INDUCES PROTECTIVE IMMUNE-RESPONSES IN BALB/C MICE THAT ARE SIMILAR TO THOSE GENERATED BY EXPERIMENTAL-INFECTION [J].
HANCOCK, GE ;
SPEELMAN, DJ ;
FRENCHICK, PJ ;
MINEOKUHN, MM ;
BAGGS, RB ;
HAHN, DJ .
VACCINE, 1995, 13 (04) :391-400
[8]  
HELLING F, 1995, CANCER RES, V55, P2783
[9]  
KENSIL CR, 1991, J IMMUNOL, V146, P431
[10]   PHASE-1 TRIAL OF IMMUNOLOGICAL ADJUVANT QS-21 WITH A GM2 GANGLIOSIDE-KEYHOLE LIMPET HEMOCYANIN CONJUGATE VACCINE IN PATIENTS WITH MALIGNANT-MELANOMA [J].
LIVINGSTON, PO ;
ADLURI, S ;
HELLING, F ;
YAO, TJ ;
KENSIL, CR ;
NEWMAN, MJ ;
MARCIANI, D .
VACCINE, 1994, 12 (14) :1275-1280